双回波化学位移成像鉴别透明细胞肾细胞癌胰腺转移与胰腺神经内分泌肿瘤
回顾性分析双回波梯度回波化学位移MRI能否鉴别透明细胞肾细胞癌胰腺转移(PM-ccRCC)与胰腺神经内分泌肿瘤(pNET)。纳入11例PM-ccRCC和24例pNET患者,测量同相位与反相位信号并计算信号强度指数(SII)和肿瘤/脾比值(TSR)。SII与TSR在两组间差异均有统计学意义(P<0.001),SII曲线下面积0.917、TSR曲线下面积0.902,SII阈值8.1%时敏感度90.9%、特异度91.7%。
要点
- SII阈值8.1%鉴别PM-ccRCC与pNET:敏感度90.9%、特异度91.7%、准确率91.4%。
- TSR截断值-4.7%鉴别两组:敏感度79.2%、特异度90.9%、准确率82.9%。
- PM-ccRCC的SII(20.3%±16.8%)高于pNET(-3.2%±11.4%),TSR(-19.2%±16.6%)低于pNET(6.0%±13.8%)。
核心结论
- 双回波GRE化学位移MRI能准确鉴别PM-ccRCC与pNET。
研究设计与样本
- 回顾性研究,纳入11例PM-ccRCC和24例pNET患者,均行化学位移成像、T2WI、DWI和DCE-MRI。
关键影像表现/征象
- PM-ccRCC的SII为20.3%±16.8%,pNET为-3.2%±11.4%,两组差异有统计学意义(P<0.001)。
- PM-ccRCC的TSR为-19.2%±16.6%,pNET为6.0%±13.8%,两组差异有统计学意义(P<0.001)。
诊断标准与关键数值
- SII鉴别PM-ccRCC与pNET的AUC为0.917。
- TSR鉴别PM-ccRCC与pNET的AUC为0.902。
- SII阈值8.1%:敏感度90.9%、特异度91.7%、阳性预测值90.1%、阴性预测值91.7%、准确率91.4%。
- TSR截断值-4.7%:敏感度79.2%、特异度90.9%、阳性预测值90.9%、阴性预测值79.2%、准确率82.9%。
临床应用与阅片要点
- 在胰腺肿瘤鉴别中可测量同相位与反相位信号并计算SII和TSR,辅助区分PM-ccRCC与pNET。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The purpose of the study was to retrospectively analyze whether double-echo gradient-echo (GRE) chemical shift imaging (CSI) can differentiate between pancreatic metastases from clear cell renal cell carcinoma (PM-ccRCC) and pancreatic neuroendocrine tumor (pNET).
METHODS: Institutional review board approval and informed consent were waived. CSI, T2WI, DWI, and DCE magnetic resonance imaging (MRI) were performed in patients with PM-ccRCC and pNET. Eleven patients with PM-ccRCC and 24 patients with pNET were enrolled into this retrospective study. The signal intensity was measured in the pancreatic tumor and spleen on in-phase and opposed-phase images. The signal intensity index (SII) and tumor-to-spleen ratio (TSR) in PM-ccRCC and pNET were calculated and compared. Receiver operating characteristic (ROC) analysis was performed to evaluate the diagnostic accuracy of SII and TSR in the differentiation between PM-ccRCC and pNET.
RESULTS: The SII between PM-ccRCC and pNET (20.3% ± 16.8% vs. - 3.2% ± 11.4%) was significantly different (P < 0.001), as was the TSR (- 19.2% ± 16.6% vs. 6.0% ± 13.8%) (P < 0.001). The area under the ROC curve was 0.917 for the SII and 0.902 for the TSR. Additionally, an SII threshold value of 8.1% permitted the differentiation of PM-ccRCC from pNET with a sensitivity of 90.9%, a specificity of 91.7%, a positive predictive value of 90.1%, a negative predictive value of 91.7%, and an accuracy of 91.4%. A TSR cut-off value of - 4.7% enabled the differentiation of the two groups with a sensitivity of 79.2%, a specificity of 90.9%, a positive predictive value of 90.9%, a negative predictive value of 79.2% and an accuracy of 82.9%.
CONCLUSION: Double-echo GRE chemical shift MR imaging can accurately differentiate between PM-ccRCC and pNET.
引用
- Lyu HL, Cao JX, Wang HY, et al. Differentiation between pancreatic metastases from clear cell renal cell carcinoma and pancreatic neuroendocrine tumor using double-echo chemical shift imaging. Abdom Radiol (NY). 2018. PMID: 29500651. doi:10.1007/s00261-018-1539-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。